Abstract
We evaluated the percent of acute respiratory viral infections with gastrointestinal syndrome in the structure of morbidity in babies aging 6 months and elder. Therapeutic efficiency and safety of anaferon (pediatric formuation) as a component of complex therapy of acute respiratory viral infections with involvement of the gastrointestinal tract were proven; more rapid disappearance of all symptoms and improvement of the immune status parameters were demonstrated.
Publication types
-
Randomized Controlled Trial
MeSH terms
-
Antibodies / therapeutic use*
-
Antiviral Agents / therapeutic use*
-
Child, Preschool
-
Female
-
Gastrointestinal Diseases / drug therapy*
-
Gastrointestinal Diseases / virology
-
Humans
-
Infant
-
Interferon Inducers / therapeutic use*
-
Male
-
Respiratory Tract Infections / drug therapy*
-
Respiratory Tract Infections / virology
-
Treatment Outcome
-
Virus Diseases / drug therapy*
-
Virus Diseases / virology
Substances
-
Antibodies
-
Antiviral Agents
-
Interferon Inducers
-
anaferon